Cost and controversy are limiting use of new Alzheimer's drug

By Jon Hamilton

Published November 8, 2021 at 5:37 AM EST

Jon Hamilton

Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience and health risks.